RNO 0.00% 4.0¢ rhinomed limited

vibrovein, page-40

  1. 755 Posts.

    Such a shame that this product is not a priority for the company.

    It is a product that does not need approvals for its usage, it is a volume sales product for medical and veterinary.

    World wide sales of Vibrovein would far outweigh the Rhino.

    Rhino would never pass the requirements for contact sports and could be quite dangerous in some non contact sports. For drug usage it will require many years of approved testing.
    For snoring it may be of some assistance, but the new surgery available to shave the back of the tongue(Rhino does not do anything past the Nose) is a long term solution claimable on Medicare and Health Insurance.

    VIBROVEIN could have been and be on the market and generating income to fund research on other products without the need for capital raisings. Instead the Company has been renamed and rebranded tying it to Nasal only products.

    IMO DYOR



 
watchlist Created with Sketch. Add RNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.